A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)
Status:
Completed
Trial end date:
2008-12-02
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to assess the safety, tolerability, and
immunogenicity potential of romosozumab following multiple subcutaneous (SC) administrations
in healthy men and postmenopausal women with low bone mass.